Science & Enterprise subscription

Follow us on Twitter

  • A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered… https://t.co/cZ13M2gPJk
    about 20 hours ago
  • New post on Science and Enterprise: Biotech Creating More Efficient Crispr Therapies https://t.co/JAfb7hBMoH #Science #Business
    about 20 hours ago
  • I have a Mode joke. It was a Moderna joke, but a messenger lost the RNA.
    about 2 days ago
  • Behind the scenes, CEPI and BARDA were funding vaccine development and covering manufacturing costs. They helped ge… https://t.co/4F5vMbVsrK
    about 3 days ago
  • A YouGov survey taken earlier this month indicates the U.S. public largely supports rejoining the Paris climate agr… https://t.co/eJd2v8G7K8
    about 3 days ago

Please share Science & Enterprise

Univ, Industry Labs Study Inhaled Covid-19 Antibodies

Adeno-associated virus

Researchers at University of Pennsylvania and Regeneron are studying delivery of synthetic antibodies directly to the nose to prevent Covid-19 infections. . . . → Read More: Univ, Industry Labs Study Inhaled Covid-19 Antibodies

Biotech Creating More Efficient Crispr Therapies

DNA puzzle

A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered with more efficient synthetic proteins. . . . → Read More: Biotech Creating More Efficient Crispr Therapies

Natural-Killer Cell Cancer Therapy Biotech Launches

Natural killer cell

A new company is underway creating off-the-shelf engineered cells from the immune system as cancer treatments, and raising $42 million in venture funds. . . . → Read More: Natural-Killer Cell Cancer Therapy Biotech Launches

Biotech Manufacturing, Distribution Company Underway

Vaccine vials

A new enterprise providing manufacturing and supply chain services for biotechnology labs, including gene and RNA therapy developers, began operations. . . . → Read More: Biotech Manufacturing, Distribution Company Underway

Infographic – Vaccines Boost Biotech Shares

Biotech share prices chart

News of those trials fueled healthy share price rises for the biotechnology companies developing the vaccines, shown in this weekend’s infographic. . . . → Read More: Infographic – Vaccines Boost Biotech Shares

Stem Cell Respiratory Therapy Licensed in $1.4B Deal

Inspecting lung X-rays

Global drug maker Novartis is acquiring a stem cell-based treatment for a serious respiratory disease associated with Covid-19 infections. . . . → Read More: Stem Cell Respiratory Therapy Licensed in $1.4B Deal

Nanoscale Particles Deliver Crispr Cancer Treatments

Crispr-Cas9 illustration

Researchers in Israel developed techniques to deliver gene editing therapies with lipid nanoscale particles that in lab mice killed cancer cells and increased survival. . . . → Read More: Nanoscale Particles Deliver Crispr Cancer Treatments

Cancer Immune System Therapy Start-Up Raises $53M

T-cells illustration

A company developing treatments that retune the immune system to kill solid tumor and blood-related cancers is raising $53 million in its first venture funding. . . . → Read More: Cancer Immune System Therapy Start-Up Raises $53M

FDA Grants Emergency Clearance for Home Covid-19 Test

Lucira test

The Food and Drug Administration gave an emergency authorization for a self-collected Covid-19 diagnostic test, the first such test for home use. . . . → Read More: FDA Grants Emergency Clearance for Home Covid-19 Test

ALS Stem Cell Therapy Fails to Meet Trial Objective

Neurons

Clinical trial results of an amyotrophic lateral sclerosis, or ALS, therapy do not show slower disease progression among patients compared to a placebo. . . . → Read More: ALS Stem Cell Therapy Fails to Meet Trial Objective